Q2 2022 13F Holders as of 30 Jun 2022
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
52.4M
-
Number of holders
-
111
-
Total 13F shares, excl. options
-
32.1M
-
Shares change
-
+1.91M
-
Total reported value, excl. options
-
$423M
-
Value change
-
+$23M
-
Put/Call ratio
-
1.53
-
Number of buys
-
64
-
Number of sells
-
-33
-
Price
-
$13.20
Significant Holders of 2seventy bio, Inc. - Common Stock (TSVT) as of Q2 2022
132 filings reported holding TSVT - 2seventy bio, Inc. - Common Stock as of Q2 2022.
2seventy bio, Inc. - Common Stock (TSVT) has 111 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 32.1M shares
of 52.4M outstanding shares and own 61.24% of the company stock.
Largest 10 shareholders include EcoR1 Capital, LLC (3.5M shares), WELLINGTON MANAGEMENT GROUP LLP (2.91M shares), STATE STREET CORP (2.49M shares), VANGUARD GROUP INC (2.33M shares), BAKER BROS. ADVISORS LP (2.06M shares), ARMISTICE CAPITAL, LLC (1.6M shares), Madison Avenue Partners, LP (1.51M shares), Bain Capital Life Sciences Investors, LLC (1.41M shares), Newtyn Management, LLC (1.35M shares), and RTW INVESTMENTS, LP (1.23M shares).
This table shows the top 111 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.